Bruker Corporation Acquires Nion

Bruker Corporation Acquires NanoString Technologies Business

May 6, 2024

Medical Devices

Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.

Bruker Corporation Acquires Neurescence Inc.

November 12, 2022

Medical Devices

Bruker Corporation has signed a definitive agreement to acquire 100% of Neurescence Inc., a Toronto-based developer of ultralight fiber‑bundle Multiscopes (Chromatone) for multi-region optical functional neuroimaging. The acquisition strengthens Bruker's preclinical neuroscience imaging capabilities and complements its existing Ultima multiphoton solutions and recently acquired Inscopix products; financial terms were not disclosed.

Agilent Technologies Acquires e-MSion

March 9, 2023

Medical Devices

Agilent Technologies has acquired e-MSion, the early-stage company behind the ExD cell electron capture dissociation (ECD) technology for benchtop mass spectrometers. The purchase brings e-MSion's ExD cell and associated tools into Agilent's life-sciences instrument portfolio to expand biopharma characterization capabilities and make ECD accessible to a broader set of labs.

Bruker Corporation Acquires Spectral Instruments Imaging

February 6, 2024

Medical Devices

Bruker Corporation has acquired Spectral Instruments Imaging LLC, a Tucson-based maker of preclinical in‑vivo optical imaging systems, to broaden Bruker BioSpin's preclinical imaging portfolio. Financial terms were not disclosed; SII generated over $10 million in revenue in 2023 and will expand Bruker's capabilities in bioluminescence, fluorescence and X‑ray preclinical imaging.

Bruker Corporation Acquires PhenomeX Inc.

August 17, 2023

Biotechnology

Bruker Corporation agreed to acquire PhenomeX Inc. in an all-cash transaction valued at roughly $108 million (purchase price $1.00 per share). PhenomeX — formed from the combination of Berkeley Lights and IsoPlexis and provider of single-cell biology instruments, software and reagents — will be folded into a Bruker subsidiary, marking Bruker’s entry into single-cell biology research tools and complementing its spatial biology offerings.

Nokia Acquires Elenion Technologies

February 19, 2020

Telecommunications

Nokia announced it will acquire Elenion Technologies, a privately held U.S. silicon photonics company headquartered in New York, to integrate Elenion's silicon photonics platform and design services into Nokia's optical networking portfolio. The acquisition is intended to improve time-to-market and reduce cost per bit for 5G, cloud and enterprise networking solutions; the transaction was expected to close in Q1 2020, subject to regulatory approvals.